Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

Products

ASX Announcement: Supply Agreement for Respiratory Products in the UK

Sep 5, 2014AaronNews

Medical Developments International (MVP) is delighted to advise it has entered into an exclusive agreement with PSUK to supply its range of respiratory devices in the UK.

The agreement includes minimum quantities for the next 3 years that will drive ongoing sales growth of MVP respiratory devices in the UK.

PSUK’s parent company, Phoenix Healthcare Distribution Ltd, is the third largest pharmaceutical and medical device wholesaler in the UK and Europe’s largest.

MVP’s CEO Mr John Sharman said “the agreement represents a substantial commercial opportunity to grow our business in the UK.  PSUK supply the majority of doctors and pharmacies in the UK with medical devices.  This is a significant opportunity for MVP and further validation of our world class range of Respiratory Medical Devices.  We are now in a position where we have a quality partner who can aggressively win market share in the UK and we expect over time sales volumes will be significant.”

Mr Sharman also reported that MVP has just made its first sales into Belgium and the Netherlands. “On top of distribution agreements for Italy and Greece signed this year, we now have building blocks in place for a solid business in Europe”, he said.

ASX Annoucement – 22.8.14

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter